for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Symrise AG

SY1G.DE

Latest Trade

85.20EUR

Change

0.86(+1.02%)

Volume

237,864

Today's Range

84.22

 - 

85.20

52 Week Range

64.16

 - 

90.24

As of on the XETRA ∙ Minimum 15 minute delay

Latest Developments

Symrise Receives U.S. Department Of Justice Clearance For ADF/IDF Acquisition

Nov 4 (Reuters) - Symrise AG <SY1G.DE>::DGAP-NEWS: SYMRISE SUCCESSFULLY CLOSES ACQUISITION OF ADF/IDF.CLEARANCE RECEIVED FROM ANTITRUST DIVISION OF U.S. DEPARTMENT OF JUSTICE TO ACQUIRE ADF/IDF.INTEGRATION PROCESS TO BEGIN IMMEDIATELY.

U.S. seeks to block Symrise's proposed acquisition of IDF/ADF -court filing

Oct 30 (Reuters) - Symrise AG <SY1G.DE>::U.S. ASKS COURT TO BLOCK SYMRISE'S PROPOSED ACQUISITION OF INTERNATIONAL DEHYDRATED FOODS, AMERICAN DEHYDRATED FOODS -COURT FILING.

Symrise Confirms Outlook As 9M Sales Grew 7%

Oct 29 (Reuters) - Symrise AG <SY1G.DE>::9M SALES 2.551 BILLION EUR.DGAP-NEWS: SYMRISE WITH CONTINUED SALES GROWTH OF 7.1 %.COMPANY REAFFIRMS OUTLOOK FOR 2019 AND LONG-TERM TARGETS.9M GROUP SALES INCREASE TO EUR 2,551 MILLION.7.1 % GROWTH IN REPORTING CURRENCY.LONG-TERM TARGETS ALSO REMAIN FULLY IN EFFECT.ADF/IDF DEAL IS EXPECTED TO CLOSE IN Q4 OF 2019.

Symrise Appoints Winfried Steeger As Chairman Of Supervisory Board

Aug 7 (Reuters) - SYMRISE AG <SY1G.DE>::DR WINFRIED STEEGER - NEW CHAIRMAN OF THE SUPERVISORY BOARD.PREVIOUS CHAIRMAN OF SUPERVISORY BOARD, DR THOMAS RABE, DECIDED TO RESIGN WITH EFFECT AS OF AUG 7 2019.RESIGNATION OF DR RABE AS CHAIRMAN OF SUPERVISORY BOARD IS CONNECTED TO HIS ELECTION AS MEMBER OF SUPERVISORY BOARD OF ADIDAS.RABE WILL REMAIN AND CONTINUE AS MEMBER OF SUPERVISORY BOARD.

Symrise Acquires Italian Biotech Company Cutech

May 6 (Reuters) - Symrise AG <SY1G.DE>::DGAP-NEWS: SYMRISE ACQUIRES ITALIAN BIOTECH COMPANY CUTECH.

Symrise Q1 Sales Rise By 9.3 Pct To 848.8 Mln Eur

April 30 (Reuters) - Symrise AG <SY1G.DE>::DGAP-NEWS: SYMRISE POSTS STRONG GROWTH OF 9.3 % IN THE FIRST QUARTER.Q1 SALES ROSE 9.3 PERCENT TO 848.8 MILLION EUR.SYMRISE GROUP REMAINS ON TRACK FOR STRONG GROWTH IN FISCAL YEAR 2019 WITH A HIGH SALES INCREASE BY 9.3 % TO EUR 848.8 MILLION (Q1 2018: EUR 776.9 MILLION) IN Q1.WE ARE CONFIDENT ABOUT DEVELOPMENT OF OUR BUSINESS IN COMING MONTHS.WE HAVE SUBSTANTIATED OUR FULL-YEAR GUIDANCE AND OUR LONG-TERM AMBITIONS WITH UPDATED TARGETS. EXTENDING THROUGH TO 2025, THEY CALL FOR AN ANNUAL ORGANIC GROWTH OF 5-7 % (CAGR).GROUP INTENDS TO SIGNIFICANTLY EXCEED ANTICIPATED WORLDWIDE MARKET GROWTH RATE FOR 2019, PROJECTED BY EXPERTS TO LIE IN RANGE OF 3-4 %.UNDER ITS UPDATED LONG-TERM TARGETS, SYMRISE AIMS TO INCREASE SALES TO AROUND EUR 5.5 TO 6.0 BILLION BY END OF 2025..THIS INCREASE IS TO BE ACHIEVED THROUGH ANNUAL ORGANIC GROWTH OF 5-7 % (CAGR) AND ADDITIONAL TARGETED ACQUISITIONS..IN JANUARY SYMRISE ANNOUNCED PLANNED ACQUISITION OF US-AMERICAN COMPANY ADF/IFD, A MEAT AND EGG-BASED PROTEIN SPECIALIST, DEAL EXPECTED TO CLOSE IN H2 2019.

Symrise Chairman Rabe Resigns, But Will Remain Board Member

April 26 (Reuters) - Symrise AG <SY1G.DE>::DGAP-ADHOC: SYMRISE AG: NEW CHAIRMAN OF SUPERVISORY BOARD.DR THOMAS RABE WILL RESIGN AS CHAIRMAN.RABE WILL REMAIN TO BE A MEMBER OF SUPERVISORY BOARD.SUPERVISORY BOARD INTENDS TO RESOLVE ON ELECTION OF A NEW CHAIRMAN OF SUPERVISORY BOARD ON SCHEDULED MEETING OF SUPERVISORY BOARD ON AUGUST 7.RESIGNATION OF DR THOMAS RABE IS CONNECTED TO DECISION OF ADIDAS TO RECOMMEND HIM AS MEMBER OF SUPERVISORY BOARD OF ADIDAS.

Symrise: We Don't Need Capital Measures To Reach L-T Targets

March 13 (Reuters) - Symrise AG <SY1G.DE> CEO::IT WILL BE HARD TO BRING COBELL TO AN EBITDA MARGIN OF 20 PERCENT.LONG TERM TARGETS WILL NOT REQUIRE CAPITAL MEASURES, THIS WOULD ONLY BE NEEDED FOR BIG ACQUISITIONS WHICH ARE NOT PLANNED AT THE MOMENT.

Symrise Reports 2018 Net Profit Rise Of 1.9 Pct

March 13 (Reuters) - Symrise AG <SY1G.DE>::FY NET PROFIT ROSE 1.9 PERCENT TO 275 MILLION EUR.FY EBITDA 631 MILLION EUR VERSUS 630 MILLION EUR YEAR AGO.DGAP-NEWS: SYMRISE SUCCESSFULLY CONTINUES PROFITABLE GROWTH COURSE IN 2018.DIVIDEND 0.90 EURPER SHARE.FY SALES ROSE 5.3 PERCENT TO 3.154 BILLION EUR.STRONG ORGANIC SALES GROWTH OF 8.8 %.SALES INCREASE OF 5.3 % TO EUR 3,154 MILLION (REPORTING CURRENCY).SOLID EARNINGS WITH EBITDA AT EUR 631 MILLION AND EBITDA MARGIN AT 20.0 %.NET INCOME INCREASES TO OVER EUR 275 MILLION.DIVIDEND INCREASE TO EUR 0.90 PER SHARE PROPOSED.CONFIDENT OUTLOOK FOR 2019 AND AMBITIOUS LONG-TERM TARGETS UNTIL END OF 2025.SYMRISE IS TARGETING AN EBITDA MARGIN OF AROUND 20 % DESPITE ANTICIPATED ECONOMIC SLOWDOWN.SYMRISE IS TARGETING AN EBITDA MARGIN OF AROUND 20 % DESPITE ANTICIPATED ECONOMIC SLOWDOWN, ONGOING VOLATILITY IN EXCHANGE RATES AND A TIGHT MARKET FOR RAW MATERIALS.

Symrise Sells New Shares At 71.25 Eur

Feb 8 (Reuters) - Symrise AG <SY1G.DE>::DGAP-ADHOC: SYMRISE AG: SYMRISE SETS PLACEMENT PRICE OF NEW SHARES - 5,614,036 SHARES SUCCESSFULLY PLACED..SUCCESSFULLY PLACED 5,614,036 NEWLY ISSUED ORDINARY BEARER SHARES TO INSTITUTIONAL INVESTORS IN A PRIVATE PLACEMENT BY WAY OF AN ACCELERATED BOOKBUILDING PROCESS.NEW SHARES WERE ISSUED IN A CAPITAL INCREASE BY PARTIALLY EXERCISING COMPANY'S AUTHORIZED CAPITAL UNDER EXCLUSION OF SHAREHOLDER'S SUBSCRIPTION RIGHTS.PLACEMENT PRICE FOR NEW SHARES HAS BEEN SET AT EUR 71.25.COMPANY WILL RECEIVE GROSS PROCEEDS OF AROUND EUR 400,000,065.00.NET PROCEEDS FROM CAPITAL INCREASE WILL BE USED FOR PARTIAL REFINANCING OF BRIDGE FACILITY IN CONNECTION WITH ACQUISITIONS.COMPANY'S SHARE CAPITAL AFTER COMPLETION OF CAPITAL INCREASE WILL AMOUNT TO EUR 135,426,610.00.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up